Published in J Dent (Tehran) on September 30, 2012
Comparative Assessment of Intelligence Quotient among Children Living in High and Low Fluoride Areas of Kutch, India-a Pilot Study. Iran J Public Health (2013) 0.91
Relationship Between Dental Fluorosis and Intelligence Quotient of School Going Children In and Around Lucknow District: A Cross-Sectional Study. J Clin Diagn Res (2015) 0.89
Effect of fluoridated water on intelligence in 10-12-year-old school children. J Int Soc Prev Community Dent (2016) 0.85
Fluoride and arsenic exposure impairs learning and memory and decreases mGluR5 expression in the hippocampus and cortex in rats. PLoS One (2014) 0.79
Contributions of a Child's Built, Natural, and Social Environments to Their General Cognitive Ability: A Systematic Scoping Review. PLoS One (2016) 0.78
Sodium fluoride induces apoptosis through the downregulation of hypoxia-inducible factor-1α in primary cultured rat chondrocytes. Int J Mol Med (2013) 0.75
Effect of Fluoride Concentration in Drinking Water on Intelligence Quotient of 12-14-Year-Old Children in Mathura District: A Cross-Sectional Study. J Int Soc Prev Community Dent (2017) 0.75
The Raven's progressive matrices: change and stability over culture and time. Cogn Psychol (2000) 2.90
Neurotoxicity of sodium fluoride in rats. Neurotoxicol Teratol (1995) 2.23
Arsenic and fluoride exposure in drinking water: children's IQ and growth in Shanyin county, Shanxi province, China. Environ Health Perspect (2007) 2.03
Decreased intelligence in children and exposure to fluoride and arsenic in drinking water. Cad Saude Publica (2007) 1.61
IQ and the association with myopia in children. Invest Ophthalmol Vis Sci (2004) 1.35
The relationships between low levels of urine fluoride on children's intelligence, dental fluorosis in endemic fluorosis areas in Hulunbuir, Inner Mongolia, China. J Hazard Mater (2010) 1.19
Superior fluid intelligence in children with Asperger's disorder. Brain Cogn (2007) 1.18
Groundwater quality in some villages of Haryana, India: focus on fluoride and fluorosis. J Hazard Mater (2004) 1.06
Relation between dental fluorosis and intelligence quotient in school children of Bagalkot district. J Indian Soc Pedod Prev Dent (2011) 1.04
Water quality and dental fluorosis. Indian J Public Health (1981) 0.85
Effect of sodium fluoride on the expression of bcl-2 family and osteopontin in rat renal tubular cells. Biol Trace Elem Res (2006) 0.83
An evaluation of the effectiveness of water iodinator system to supply iodine to selected schools in Terengganu, Malaysia. Trop Biomed (2006) 0.82
Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study. Circulation (2000) 1.59
Wire reinforced endotracheal tube compared with Parker Flex-Tip tube for oral fiberoptic intubation: a randomized clinical trial. Minerva Anestesiol (2013) 1.45
Changes in perinatal cocaine use in an inner-city hospital, 1988 to 1992. Am J Public Health (1995) 1.38
Risk stratification for subclavian artery angioplasty: is there an increased rate of restenosis after stent implantation? J Endovasc Ther (2001) 1.01
Critical care management of potential organ donors: our current standard. Clin Transplant (2009) 0.92
Effects of oat and wheat cereals on endothelial responses. Prev Med (2001) 0.92
Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation. J Endovasc Ther (2001) 0.89
Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation. J Neurooncol (2005) 0.87
Neuropsychological outcome 6 months after unilateral carotid stenting. J Clin Exp Neuropsychol (2005) 0.85
Effects of three oral analgesics on postoperative pain following root canal preparation: a controlled clinical trial. Int Endod J (2011) 0.85
Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke (1989) 0.83
Acute effects of oats and vitamin E on endothelial responses to ingested fat. Am J Prev Med (2001) 0.82
Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? Atherosclerosis (1996) 0.80
[Pseudonormalization of diffusion weighted images: magnetic resonance imaging in an animal model (C6-glioma)]. Rofo (2005) 0.80
[Randomized comparative study of the recurrence rate following femoro-popliteal PTA: high (1.0 g/die) vs low (0.1 g/die) acetylsalicylic acid dose]. Vasa Suppl (1991) 0.80
Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients. Diabet Med (2002) 0.80
Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys (2000) 0.79
Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology (1998) 0.79
Outcome of conservative therapy of patients with severe intermittent claudication. Eur J Vasc Endovasc Surg (2004) 0.79
Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography. J Vasc Surg (1997) 0.79
Reduction in renal function after renal arteriography and after renal artery angioplasty. Eur J Vasc Endovasc Surg (2002) 0.79
Oro-dental health status and salivary characteristics in children with chronic renal failure. J Dent (Tehran) (2011) 0.79
Molecular cloning of gluconobacter oxydans DSM 2003 xylitol dehydrogenase gene. Res Pharm Sci (2011) 0.78
Prevalence and risk indicators of periodontal disease among high-school students in Tehran. East Mediterr Health J (2008) 0.78
Oral manifestations in selective IgA deficiency. Int J Dent Hyg (2004) 0.77
Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy. Thromb Haemost (1987) 0.77
Double-chimera proteins to enhance recruitment of endothelial cells and their progenitor cells. Int J Cardiol (2012) 0.77
Experimental monitoring of hepatic glucose, lactate, and glutamate metabolism by microdialysis during surgical preparation of the liver hilus. J Surg Res (2002) 0.76
Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology (2001) 0.76
Effect of intrahippocampal ghrelin agonist administration on passive avoidance learning and anxiety in rats. Pak J Biol Sci (2012) 0.76
Predicting renal failure after balloon angioplasty in high-risk patients. J Endovasc Ther (2001) 0.76
Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy. Neuropsychobiology (1984) 0.76
Teaching human rights in the medical curriculum. JAMA (1999) 0.75
An integrated residency in internal and preventive medicine. Acad Med (2000) 0.75
Clinical long-term results of percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease. Vasa (2002) 0.75
D-dimer in local thrombolytic therapy with low doses of recombinant human tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease. Thromb Haemost (1990) 0.75
[Peri-interventional drug therapy in PTA of supra-aortic blood vessels]. Radiologe (2000) 0.75
[Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease]. Vasa Suppl (1989) 0.75
Coadministration of low-dose urokinase and abciximab in thrombolysis for lower limb ischemia. a safety study. Thromb Res (2001) 0.75
Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteries. Radiology (1988) 0.75
Temporary vena cava filters do not always protect from fatal pulmonary embolism. Vasa (2000) 0.75
Clinical outcome and prognostic factors for ischaemic ulcers treated with PTA in lower limbs. Eur J Vasc Endovasc Surg (2002) 0.75
[Assessment of thrombocyte deposits and thrombocyte survival following catheter dilatation of the lower extremities using 111-indium marked thrombocytes]. Vasa Suppl (1988) 0.75
Excessive ectasia of the femoral artery: an unknown late sequel of percutaneous transluminal angioplasty: case report. Vasa (1986) 0.75
Platelet disposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries. Vasa (1989) 0.75
Clinical impact of GB-C virus in haemodialysis patients. Nephrol Dial Transplant (1998) 0.75
Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries. Radiology (1989) 0.75